Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of Dioxidin in Healthy Volunteers
NCT05505097Phase 1Completed
- Sponsor
- Valenta Pharm
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dioxidine in bacterial infection (4 arms), sponsored by Valenta Pharm. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Plasma Concentration and 8 more. Started May 2022; status: completed.
02
Drugs
dioxidine
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05505097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05505097.